Description

AZILASE-200 SUSPENSION

AZILASE-200 Suspension by Monark Biocare is a powerful pediatric antibiotic formulation containing Azithromycin 200 mg/5 ml, specifically designed to treat a wide range of bacterial infections in children. With its superior efficacy, high patient compliance, and once-daily dosage advantage, AZILASE-200 is quickly becoming the preferred choice among pediatricians and general practitioners alike.

As bacterial resistance continues to pose a significant global challenge, particularly in pediatric care, there is an ever-growing demand for safe and potent antibiotics. AZILASE-200 meets this demand by providing fast and effective treatment while ensuring a pleasant taste for ease of administration in children. Manufactured under strict WHO-GMP guidelines, it exemplifies Monark Biocare’s commitment to quality, affordability, and patient-centric care.

About Monark Biocare

Monark Biocare is a reputed pharmaceutical company in India known for its innovative, high-quality, and affordable medicines. With a vision to provide healthcare solutions that are both effective and accessible, the company has built a strong presence across India in various therapeutic areas including pediatrics, general medicine, gastroenterology, and critical care.

All products by Monark Biocare are manufactured in WHO-GMP and ISO-certified facilities, adhering to strict quality control protocols. AZILASE-200 Suspension is one of its top-selling pediatric formulations and a flagship product in the antibiotic segment.

Composition of AZILASE-200 Suspension

Each 5 ml of AZILASE-200 Suspension contains:

• Azithromycin Dihydrate equivalent to Azithromycin 200 mg
   

The formulation is reconstituted to a 15 ml or 30 ml suspension and flavored with child-friendly ingredients to enhance palatability.

What Is Azithromycin?

Azithromycin is a macrolide antibiotic with a broad spectrum of activity against various bacterial pathogens. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial replication. Due to its long half-life and excellent tissue penetration, azithromycin allows once-daily dosing and shorter treatment durations, which are especially beneficial in children.

Therapeutic Uses of AZILASE-200 Suspension

AZILASE-200 is indicated for the treatment of mild to moderate infections caused by azithromycin-susceptible bacteria. Common indications include:

1. Upper Respiratory Tract Infections (URTIs)

• Pharyngitis
   
• Tonsillitis
   
• Sinusitis

2. Lower Respiratory Tract Infections

• Acute bronchitis
   
• Pneumonia
   
• Bronchiolitis

3. Ear Infections

• Acute otitis media

4. Skin and Soft Tissue Infections

• Impetigo
   
• Folliculitis
   
• Abscesses

5. Pediatric Dental Infections

• Gingivitis
   
• Dental abscess

6. Gastrointestinal Infections

• Bacterial diarrhea (including traveler’s diarrhea caused by E. coli)
   

Due to its excellent spectrum and high tolerability, AZILASE-200 is often chosen as first-line therapy for children with respiratory and skin infections.

Dosage and Administration

Standard Pediatric Dosage:
 

• 10 mg/kg body weight once daily for 3 days
  or
   
• Day 1: 10 mg/kg
  Day 2 to 5: 5 mg/kg/day
   

How to Use:

• Shake the bottle well before each use.

• Administer with a measuring cup or spoon.
   
• Use within 5 days of reconstitution.
   
• Store below 25°C in a dry place, away from direct sunlight.
   

Always follow the pediatrician’s dosage instructions based on age and body weight.

How it works?

Azithromycin binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting the translocation steps in protein synthesis. This leads to the inhibition of bacterial growth (bacteriostatic action) and eventual elimination of infection. Its high tissue penetration allows the antibiotic to concentrate in infection sites, ensuring fast and effective results.

Key Benefits of AZILASE-200 Suspension

Once-Daily Dosing: Enhances compliance and ease of use for parents and children.

Short-Course Therapy: Usually administered for just 3 to 5 days, reducing antibiotic burden.

Pleasant Taste: Child-friendly flavor ensures better acceptance and minimal resistance to intake.

 Broad Spectrum: Effective against Gram-positive, Gram-negative, and atypical bacteria.

 High Safety Profile: Well tolerated in most pediatric patients, including infants above 6 months.

 Fast Onset of Action: Symptoms like fever, sore throat, and cough improve within 24-48 hours.

Side Effects and Safety

AZILASE-200 Suspension is generally safe and well tolerated. However, some mild side effects may include:

• Nausea
   
• Vomiting
   
• Mild diarrhea
   
• Abdominal cramps
   
• Headache
   

Rare but serious side effects (extremely uncommon):

• Allergic reactions (rash, itching)
   
• Liver enzyme elevations
   
• QT prolongation (in pre-existing cardiac conditions – use with caution)
   

Precautions:

• Avoid use in children allergic to azithromycin, erythromycin, or other macrolides.
   
• Use cautiously in children with liver or kidney issues.
   
• Should not be taken with antacids containing magnesium or aluminum within 2 hours.

Why Pediatricians Trust AZILASE-200 Suspension

• Backed by clinical efficacy and global usage data
   
• Suitable for younger age groups including toddlers
   
• Offers broad antimicrobial coverage
   
• Supported by Monark Biocare’s excellent quality control
   
• Once-daily dosage simplifies administration and improves treatment adherence

Why AZILASE-200 is a Top Choice for Pharma Distributors and Franchise Partners

• High Market Demand: Pediatric antibiotics are consistently among the top-selling therapeutic classes in India.
   
• Regular Prescriptions: URTIs, otitis media, and skin infections are year-round occurrences in children.
   
• Repeat Business: Doctors frequently prescribe it for common infections, ensuring consistent demand.
   
• Attractive Margins: High-profit potential due to reasonable cost and high turnover.
   
• Monark Biocare Support: Promotional material, MR bags, visual aids, doctor samples, and monopoly rights.
   

Market Trends – Pediatric Antibiotics in 2025

The pediatric antibiotic market is witnessing steady growth due to:

• Rising awareness among parents about early infection treatment
   
• Increasing population of children under age 12
   
• Improved access to healthcare in semi-urban and rural areas
   
• Shift towards short-course, broad-spectrum antibiotics like azithromycin
   

By 2025, the pediatric antibiotic market in India is expected to cross ₹2,500 crores, with macrolides like azithromycin playing a dominant role.

Monark Biocare – A Partner You Can Trust

Why choose Monark Biocare?

• WHO-GMP & ISO certified pharma company
•  Transparent pricing and ethical business practices
•  Fast order processing and consistent availability
•  Territory-wise monopoly for franchise partners
•   Ongoing support in marketing and distribution

With a strong reputation across India, Monark Biocare is helping hundreds of distributors and franchise partners build successful pharma businesses. AZILASE-200 Suspension is one of the best-selling and most trusted products in its pediatric lineup.

Conclusion: AZILASE-200 – Reliable, Effective, and Profitable

In summary, AZILASE-200 Suspension is a safe, powerful, and well-accepted pediatric antibiotic that meets modern clinical and commercial expectations. Backed by Monark Biocare’s manufacturing excellence, ethical branding, and pan-India presence, it is a must-have product for pediatricians, parents, and pharma business professionals.

Whether you're a doctor looking for an effective prescription or a distributor seeking a fast-moving, profitable product—AZILASE-200 Suspension is the right choice.